// April 17, 2023
USP’s Preferential Access for Regulators (PAR) Program: Supporting the Global Supply of Quality Medicines
In the U.S. and around the world, quality standards developed by the U.S.
In the U.S. and around the world, quality standards developed by the U.S.
USP has launched the newest tool in our suite of solutions to address the evolving nitrosamines c
Revised on: January 17, 2023
The COVID-19 pandemic exacerbated vulnerabilities in the global medicines supply chain, leading t